BMJ  2005;330 (16 April), doi:10.1136/bmj.330.7496.0-g

Editor's choice

Say no to the free lunch

Are you a pig or a weasel? Or do you consider yourself above all that? When the BMJ published a special issue on the links between doctors and drug companies in 2003, the cover showed pigs in white coats lunching and golfing with weasel drug reps. At the time this seemed strong stuff even to those involved in editing the issue. But little has happened since to suggest that the image was wrong. In fact, every day new revelations suggest that the reality is worse.

The power of drug companies to buy influence over every key group in health care—doctors, charities, patient groups, journalists, politicians—has clearly shocked a UK parliamentary committee (p 855). It should shock us all. Can we console ourselves that companies' lavish spending on research and marketing, which far outstrips spending on independent research and drug information, leads to truly innovative treatments? No, says the committee's report. Can we rely on regulatory bodies to keep the industry in check? No, again.

What we can rely on, says Slattery-Moschkau, a former drug rep and creator of a hard hitting new film on the industry (p 911), is that drug reps are "armed and dangerous," selected for their ability to seduce and persuade rather than their scientific skills, and armed with, among other things, details of your prescribing behaviour.

All of this might encourage new resolve to step away from the trough and stand with the good guys. So it's interesting that the American College of Physicians has refused a booth at its annual meeting to the not-for-profit group No Free Lunch, which works to reduce conflicts of interest (p 862). Interesting, too, that the US National Institutes of Health may be forced to relax its policy on conflict of interest in response to protests from staff that it is too restrictive (p 864).

The BMJ, like most academic medical journals that carry pharmaceutical advertising, is perhaps somewhere between a pig and a weasel. And those of you alert to competing interests will see that Gauthier (p 857), in line with our policy on disclosure, lists at the end of his editorial several companies he has received funding from. We take the pragmatic view that competing interests cannot be removed altogether, since few clinical experts do not have some links to industry. But this is a hard balance to keep, and perhaps we delude ourselves that we have got it right.

Ferner (p 855) indicates that "professional self delusion"—doctors' view that they are not influenced by marketing—may force external regulation. The committee recommends, for example, requiring clinicians to register all substantial gifts from industry. It also recommends limits to promotion aimed at inexperienced prescribers and more training for medical students about marketing by drug companies.

So when the drug reps call for a chat, or offer to throw a sponsored lunch, make sure you are armed with cynicism, or information, or both. Better still—however seductive they are, just say no.

Fiona Godlee, editor

(fgodlee{at}bmj.com)

To receive Editor's choice by email each week subscribe via our website: bmj.com/cgi/customalert


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Articles

The influence of big pharma
R E Ferner
BMJ 2005 330: 855-856. [Extract] [Full Text] [PDF]

Drugs for Alzheimer's disease and related dementias
Serge Gauthier
BMJ 2005 330: 857-858. [Extract] [Full Text] [PDF]

In brief
BMJ 2005 330: 862. [Extract] [Full Text] [PDF]

New rules drive off NIH researchers
Janice Hopkins Tanne
BMJ 2005 330: 864. [Extract] [Full Text]

Confessions of a drug rep
Jeanne Lenzer
BMJ 2005 330: 911. [Extract] [Full Text]

Rapid Responses:

Read all Rapid Responses

Yes But
Rex C Paddy
bmj.com, 15 Apr 2005 [Full text]
Hypocritical tosh - an alternative editorial
Clifford G. Miller
bmj.com, 16 Apr 2005 [Full text]
Wind of Change
John Stone
bmj.com, 15 Apr 2005 [Full text]
The Dilemma of Pharma
F C Gray Southon
bmj.com, 15 Apr 2005 [Full text]
Doctors should decide whether they want to be pigs or not!
Farokh Wadia
bmj.com, 18 Apr 2005 [Full text]
Do not ask for a sacrifice without an alternative in hand
Mansur Ilahi
bmj.com, 15 Apr 2005 [Full text]
same story everywhere!!!
Vijayashankara. Nanjegowda
bmj.com, 15 Apr 2005 [Full text]
UK compared to Indian subcontinent
DR Ashan Gunarathne
bmj.com, 15 Apr 2005 [Full text]
The Splinter
B Levinson
bmj.com, 16 Apr 2005 [Full text]
Re: The Splinter
John Stone
bmj.com, 17 Apr 2005 [Full text]
How right the Editor is.
Griselda Halling
bmj.com, 17 Apr 2005 [Full text]
Sense of Proportion
Christopher G Pollock
bmj.com, 17 Apr 2005 [Full text]
The UK is very lucky to have the BMJ
Donna M Arnold
bmj.com, 17 Apr 2005 [Full text]
Culture,Tardition and Social Fabric in Community influences the Corruption
Paras K Pokharel, et al.
bmj.com, 17 Apr 2005 [Full text]
Where to find truly independent medical education?
Peter I H Parry
bmj.com, 18 Apr 2005 [Full text]
Corporatocracy
BM HEGDE
bmj.com, 19 Apr 2005 [Full text]
Fewer frills, more pills
Ann K Sullivan, et al.
bmj.com, 20 Apr 2005 [Full text]
Probity in Dealing with Industry
Adam P Fitzpatrick
bmj.com, 20 Apr 2005 [Full text]
What is the fuss about?
Pablo Millares Martin
bmj.com, 20 Apr 2005 [Full text]
Free lunches and hormone use promotions
Ellen C G Grant
bmj.com, 21 Apr 2005 [Full text]
a simple question
marcio coelho
bmj.com, 21 Apr 2005 [Full text]
Maddening Media
Gary Parkes
bmj.com, 21 Apr 2005 [Full text]
Invisible strings
John Stone
bmj.com, 21 Apr 2005 [Full text]
Re: Say No to Free Lunch (Editor’s Choice)
Leana S. Wen, et al.
bmj.com, 21 Apr 2005 [Full text]
A Question of Balance-Pharmaceutical Medicine as a Specialty
David S Millson
bmj.com, 22 Apr 2005 [Full text]
Re: A Question of Balance-Pharmaceutical Medicine as a Specialty
John Stone
bmj.com, 23 Apr 2005 [Full text]
Mad dogs, englishmen and sponsored midday luncheon.
Roger N Chitty
bmj.com, 23 Apr 2005 [Full text]
Pigs with insight
ONASEGUN G OWONIKOKO, et al.
bmj.com, 28 Apr 2005 [Full text]
Re: Re: A Question of Balance-Pharmaceutical Medicine as a Specialty
John Stone
bmj.com, 10 May 2005 [Full text]
Pharmaceutical Medicine as a Specialty
Jackie Napier
bmj.com, 10 May 2005 [Full text]
Re: Pharmaceutical Medicine as a Specialty (but if the truth will out will it make any difference)
John Stone
bmj.com, 10 May 2005 [Full text]
Re: Pharmaceutical Medicine as a Specialty
Michael D Innis
bmj.com, 11 May 2005 [Full text]
Pharmaceutical Medicine and the truth will out about hormonal contraceptives?
Ellen C G Grant
bmj.com, 11 May 2005 [Full text]
Unfortunately doctors and drug firm do depend on each other
Peter KK Au-Yeung
bmj.com, 12 May 2005 [Full text]
Re: Re: Pharmaceutical Medicine as a Specialty
Michael D Innis
bmj.com, 12 May 2005 [Full text]
Where are we 5 weeks on?
John Stone
bmj.com, 21 May 2005 [Full text]

Student BMJ

Asylum seekers' care

UK medical students have published unreleased government plans to restrict failed asylum seekers' access to medical care

www.student.bmj.com

Listen to the latest BMJ Interview